EUVIMEDEUVIMED entdecken
Crossref

Incidental Detection of Aggressive HER2-Positive Breast Cancer on 99m Tc-Sestamibi Parathyroid Scintigraphy

Mayada Elmakki, Rawy Alasaly, Ghulam Syed

Journal of Nuclear Medicine Technology · 23.06.2026 · jnmt.126.272186

DOI: 10.2967/jnmt.126.272186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine Technology, online erschienen am 23.06.2026. Verfasst von Mayada Elmakki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Hamad Medical Corporation, Doha, Qatar. Die Arbeit nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 71-y-old woman with primary hyperparathyroidism underwent 99mTc-sestamibi SPECT/CT for preoperative localization. The study showed a left inferior parathyroid adenoma and, on extended field-of-view review, an intensely 99mTc-sestamibi–avid 1.5-cm lesion in the left breast. Diagnostic mammography and ultrasonography classified the lesion as Breast Imaging Reporting and Data System category 5, prompting a core biopsy that revealed Nottingham grade 3 invasive ductal carcinoma of no special type (human epidermal growth factor receptor 2 [HER2] overexpression [3+]), with a Ki-67 index of 80%. After sentinel lymph node mapping, the patient underwent wide local excision and sentinel lymph node biopsy. Final pathology demonstrated a 1.9-cm grade 3 carcinoma with associated ductal carcinoma in situ and a 1-mm nodal micrometastasis identified in a sentinel lymph node. She completed adjuvant chemotherapy, radiotherapy, and HER2-targeted therapy, with no recurrence at 2-y follow-up. This case emphasizes deliberate review of the complete hybrid SPECT/CT field of view during parathyroid imaging.

Schlagwörter

Stichwörter der Autor:innen

SPECT/CTbreast cancerincidental findingparathyroid scintigraphysestamibi

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Department of Nuclear Medicine, Hamad Medical Corporation, Doha, Qatar ralasaly@hamad.qa.

Zitieren

APA

Elmakki, M., Alasaly, R., & Syed, G. (2026). Incidental Detection of Aggressive HER2-Positive Breast Cancer on 99m Tc-Sestamibi Parathyroid Scintigraphy. Journal of Nuclear Medicine Technology, jnmt.126.272186. https://doi.org/10.2967/jnmt.126.272186

Vancouver

Elmakki M, Alasaly R, Syed G. Incidental Detection of Aggressive HER2-Positive Breast Cancer on 99m Tc-Sestamibi Parathyroid Scintigraphy. Journal of Nuclear Medicine Technology. 2026:jnmt.126.272186. doi:10.2967/jnmt.126.272186

BibTeX
@article{Elmakki2026,
  author = {Elmakki, Mayada and Alasaly, Rawy and Syed, Ghulam},
  title = {Incidental Detection of Aggressive HER2-Positive Breast Cancer on 99m Tc-Sestamibi Parathyroid Scintigraphy},
  journal = {Journal of Nuclear Medicine Technology},
  year = {2026},
  pages = {jnmt.126.272186},
  doi = {10.2967/jnmt.126.272186}
}
Kostenlos starten →